Medical Minutes

Share

Program Content

Activities

  • Adjuvant CDK Inhibitors for EBC
    Integrating Adjuvant CDK4/6 Inhibitors Into Care of Patients With HR-Positive/HER2-Negative Early-Stage Breast Cancer
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 01, 2024

    Expires: April 30, 2025

  • BRCA Testing and Targeting in EBC
    Germline BRCA Testing and Targeting in HER2-Negative Early-Stage Breast Cancer
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 07, 2024

    Expires: May 06, 2025

  • ICIs for EBC
    Immune Checkpoint Inhibitor Therapy for HER2-Negative Early-Stage Breast Cancer
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 13, 2024

    Expires: May 12, 2025

Faculty

cover img faculity

Tanya Gupta, MD

Palo Alto Medical Foundation
Palo Alto, California

Provided by

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca, Merck Sharp & Dohme, LLC, and Novartis Pharmaceuticals Corporation.

AstraZeneca

Merck Sharp & Dohme, LLC

Novartis Pharmaceuticals Corporation

Partners

Breastcancer.org

ProCE Banner